We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601869:SSEYangtze Optical Fibre & Cable Joint Stock Ltd. Co. Class A Analysis

Data as of 2026-03-16 - not real-time

CN¥241.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Yangtze Optical Fibre and Cable is trading at CNY 241.9, comfortably above its 20‑day (CNY 224.7), 50‑day (CNY 165.0) and 200‑day (CNY 92.3) moving averages, indicating a bullish price bias. The RSI sits at 65.6, suggesting the stock is approaching overbought territory, while the MACD histogram has turned negative, flagging short‑term bearish momentum. Volatility is exceptionally high at 82.8% over the past 30 days, though the beta of 0.34 points to limited systematic risk.
Fundamentally, the company appears dramatically overvalued – a trailing P/E of 314 versus an industry average of 34, and a DCF‑derived fair value of just CNY 30.6. Revenue grew 16% YoY, yet net income and EPS fell in the latest half‑year, a trend highlighted in recent news that noted a 249% price surge despite earnings contraction. The dividend yield is a modest 0.11% with a 66% payout ratio, raising questions about sustainability given modest cash generation and a debt‑to‑equity ratio of 64%.
In this context, the stock faces high valuation and earnings‑quality risks, amplified by its sharp price swings, while the low beta and stable volume temper broader market exposure. The overall risk profile is elevated, and the outlook leans toward a defensive stance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Negative MACD momentum
  • Overbought RSI
  • Recent earnings decline despite revenue growth

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward EPS outlook suggests earnings recovery
  • Stable trading volume and low beta
  • High valuation gap remains a drag

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • DCF fair value far below market price
  • Sustained high debt levels
  • Limited dividend upside and low profitability

Key Metrics & Analysis

Financial Health

Revenue Growth16.30%
Profit Margin4.16%
P/E Ratio314.2
ROE3.89%
ROA2.00%
Debt/Equity64.08
P/B Ratio15.4
Op. Cash FlowCN¥2.9B
Free Cash FlowCN¥1.0B
Industry P/E33.7

Technical Analysis

TrendBullish
RSI65.6
SupportCN¥160.65
ResistanceCN¥266.66
MA 20CN¥224.66
MA 50CN¥164.96
MA 200CN¥92.29
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueCN¥30.64
GradeOvervalued
TypeBlend
Dividend Yield0.11%

Risk Assessment

Beta0.34
Volatility82.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.